3 Recruiting Relapse Multiple Myeloma Phase 1 Clinical Trials

Active phase 1 studies for relapse multiple myeloma enrolling across the USA. Verify eligibility and contact site coordinators.

All Relapse Multiple Myeloma studies

Phase 1 Studies for Relapse Multiple Myeloma

🟡 Not Yet Recruiting Phase1

FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma

📍 Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin

View Study & Checklist ➔

🟢 Recruiting Phase1

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma

📍 Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

📍 University of Wisconsin — Madison, Wisconsin

View Study & Checklist ➔